DRUG · COUNSELLING NOTES
Mosunetuzumab
LUNSUMIO
Updated
New prescription
indication: _____. IV by healthcare professional; report fever, confusion; warned on allergies; AEs: cytokine release syndrome, neurotoxicity, infections; non-pharm: infection precautions.
Refill prescription
refilled, adherence discussed, no SEs were reported
Dose change
Dose change discussed. new dose reviewed; IV by healthcare professional; report fever, confusion; warned on allergies; AEs: cytokine release syndrome, neurotoxicity, infections; non-pharm: infection precautions.